Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Drug Discovery and Development

Background:

• Early prediction of drug clearance mechanisms is crucial for efficient drug discovery and development.
• Understanding clearance pathways helps assess pharmacokinetic variability, drug interactions, and pharmacogenomic risks.

Purpose of the Study:

• To propose the Extended Clearance Classification System (ECCS) for predicting the primary drug clearance mechanism.
• To utilize physicochemical properties and passive membrane permeability for classification.

Main Methods:

• Compounds classified into four classes based on permeability, molecular weight, and ionization.
• Apparent permeability measured using Madin-Darby canine kidney cells.
• Ionization determined by calculated pKa at pH 7.

Main Results:

• The ECCS framework correctly predicted the rate-determining clearance mechanism for approximately 92% of tested compounds.
• Classes defined for metabolism, transporter-mediated hepatic uptake, and renal clearance.
• Validation performed on 307 compounds with a single dominant clearance mechanism (≥70%).

Conclusions:

• The ECCS framework provides a valuable tool for early prediction of drug clearance mechanisms.
• It aids in selecting appropriate preclinical tools and strategies for optimizing drug exposure.
• Facilitates evaluation of clinical risks associated with pharmacokinetic variability.